Portal de Periódicos da CAPES

Vancomycin Ototoxicity in a Patient with Normal Renal Function

1981; American College of Physicians; Volume: 95; Issue: 4 Linguagem: Inglês

10.7326/0003-4819-95-4-458

1539-3704

Peter G. Traber, Donald P. Levine,

Hearing, Cochlea, Tinnitus, Genetics

Brief Reports1 October 1981Vancomycin Ototoxicity in a Patient with Normal Renal FunctionPETER G. TRABER, M.D., DONALD P. LEVINE, M.D.PETER G. TRABER, M.D., DONALD P. LEVINE, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-95-4-458 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDespite its apparent efficacy against gram-positive organisms, vancomycin has been relegated to second-choice status, largely because of reports of auditory and nephrotoxicity. The increased purity of today's preparations has virtually elemented the risk of nephrotoxicity (1). Ototoxicity, however, is still considered a threat in patients with impaired renal function, despite the fact that all the evidence comes from reports of patients who received other ototoxic drugs or who had pre-existing deafness (1-3). We review the relevant literature and report a case of ototoxicity in a patient with normal renal function who was treated with vancomycin and rifampin but no other...References1. APPELNEU GH. The nephrotoxicity of antimicrobial agents. N Engl J Med. 1977;296:722-8. CrossrefMedlineGoogle Scholar2. ESPOSITOGLECKMAN AR. Vancomycin: a second look. JAMA. 1977;238:1756-7. CrossrefMedlineGoogle Scholar3. COOKFARRAR FW. Vancomycin revisited. Ann Intern Med. 1978;88:813-8. LinkGoogle Scholar4. GERACIHEILMANNICHOLSWELLMAN JFDW. Antibiotic therapy of bacterial endocarditis: VII. Vancomycin for acute micrococcal endocarditis: preliminary report. Proc Mayo Clin. 1958;33:172-81. MedlineGoogle Scholar5. GERACIHEILMAN JF. Vancomycin in the treatment of staphyloccal endocarditis. Mayo Clin Proc. 1960;35:316-26. MedlineGoogle Scholar6. WAISBRENKLEINERMANSKEMPBRATCHER BLJG. Comparative clinical effectiveness and toxicity of vancomycin, ristocetin, and kanamycin. Arch Intern Med. 1960;106:179-93. CrossrefGoogle Scholar7. KIRBYPERRYBAUER WDA. Treatment of staphylococcal septicemia with vancomycin: report of thirty-three cases. N Engl J Med. 1960;262:49-55. CrossrefMedlineGoogle Scholar8. DANGERFIELDHEWITTMONZONKUDINOFFBLACKMANFINEGOLD HWOZBS. Clinical use of vancomycin. Antimicrob Agents Ann. 1960;428-37. Google Scholar9. HOOKJOHNSON EW. Vancomycin therapy of bacterial endocarditis. Am J Med. 1978;65:411-5. CrossrefMedlineGoogle Scholar10. WOODLEYHULL DW. The treatment of severe staphylococcal infections with vancomycin. Ann Intern Med. 1961;55:235-49. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Detroit Receiving Hospital Wayne State University Detroit, Michigan. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByInitial Serum C-reactive Protein Level as a Predictor of Increasing Serum Vancomycin Concentration During TreatmentRegulation of Resistance in Vancomycin-Resistant Enterococci: The VanRS Two-Component SystemThe antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucinsGlycopeptide Hypersensitivity and Adverse ReactionsLong-term vancomycin use had low risk of ototoxicityOtotoxicity and Nephrotoxicity With Elevated Serum Concentrations Following Vancomycin Overdose: A Retrospective Case SeriesAntibiotic Consideration in Transplant RecipientsGlycopeptidesHunter screening design to understand the product variability of solid dispersion formulation of a peptide antibioticPractice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug MonitoringProposal of a Pharmacokinetically Optimized Dosage Regimen of Antibiotics in Patients Receiving Continuous HemodiafiltrationThe Use and Misuse of Antibiotics in NeurosurgeryGlycopeptidesComparison of the Therapeutic Efficacy of Linezolid and Vancomycin and Correlation of Serum and Tissue Malondialdehyde and Myeloperoxidase in an Experimental Mediastinitis ModelVancomycin Ototoxicity: a Reevaluation in an Era of Increasing DosesTherapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsVancomycin: Understanding Its Past and Preserving Its FutureVancomycin Use in Patients Requiring Hemodialysis: A Literature ReviewVancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infectionsWest Nile Virus infection with hearing lossVancomycin: A HistoryAntimicrobial therapy of methicillin resistant Staphylococcus aureus infectionSensorineural Hearing Loss Associated with Intrathecal VancomycinFeasibility of establishing an early indicator for ototoxicity in children using otoacoustic emissionsEvaluation of Bayesian Predictability of Vancomycin Concentration in Patients with Various Degrees of Renal Function.Population Pharmacokinetics of Vancomycin in Japanese Pediatric PatientsEffect of Cilastatin on Renal Handling of Vancomycin in RatsPopulation Pharmacokinetics of Vancomycin in Japanese Adult PatientsDevelopment of a Quantitative Vancomycin Immunoassay for the Abbott AxSYM AnalyzerVancomycin administration in continuous ambulatory peritoneal dialysis: The risk of ototoxicityPharmacodynamics of antimicrobial therapy in surgeryLack of effect of vancomycin and gentamicin on auditory function in guinea pigsInstability of Standard Calibrators May Be Involved in Overestimating Vancomycin Concentrations Determined by Fluorescence Polarization ImmunoassayTherapeutisches Drug MonitoringVancomycin Serum Concentration Monitoring: A Continued DebateHearing LossHow vancomycin is used in Australasia - A surveyOtotoxicity of Vancomycin and AnaloguesVancomycin Therapeutic Drug Monitoring: Is it Necessary?Antibiotic Choices in Surgical Intensive Care Unit PatientsResistance to vancomycin and teicoplanin: an emerging clinical problemMethicillin-Resistant Staphylococcus aureusVancomycin- and erythromycin-induced hearing loss in humansAn experimental study of vancomycin-induced cochlear damageEvaluation of Three Methods for Determining Initial Vancomycin DosesSimulation of Vancomycin Peak and Trough Concentrations Using Five Dosing Methods in 37 PatientsUse of serum drug concentrations in surgical patientsVancomycin Dosing Chart for Use in Patients With Renal ImpairmentVancomycin: A ReviewOtotoxicity of teicoplanin in the guinea pigAuditory brainstem response in young burn-wound patients treated with ototoxic drugsMonitoring Vancomycin TherapyVancomycin and the KidneyVancomycin: An UpdateActivity of coumermycin against clinical isolates of staphylococciA Simplified Dosing Method for Initiating Vancomycin TherapyAntimicrobial TherapyLaboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassayThe Neurotoxicity of Antibacterial AgentsSHARON R. SNAVELY, M.D., GLENN R. HODGES, M.D.Use of Drugs in Uremia and DialysisVancomycin ototoxicity in patients with normal renal functionComparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serumVancomycinCommunity-Acquired Methicillin-Resistant Staphylococcus aureus Endocarditis in the Detroit Medical CenterDONALD P. LEVINE, M.D., RALPH D. CUSHING, M.D., JONATHAN JUI, M.D., WILLIAM J. BROWN, Ph.D.Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureusTANIA C. SORRELL, M.B., B.S., M.D., DONALD R. PACKHAM, M.B., B.S., SIVARAJ SHANKER, B.Sc., MARY FOLDES, B.Sc., ROSEMARY MUNRO, M.B., B.S.Treatment of Infections Due to Methicillin-Resistant Staphylococcus aureusCHATRCHAI WATANAKUNAKORN, M. D.Hörstörungen 1 October 1981Volume 95, Issue 4Page: 458-460KeywordsDeafnessDrugsHospital medicineInfectious diseasesVancomycin Issue Published: 1 October 1981 PDF DownloadLoading ...